Prof. Ali Mohammad Sharifi is a scholar with over 27 years of experience in Molecular Pharmacology at the Iran University of Medical Sciences and currently joined as a professor of regenerative Medicine in the Tissue Engineering Group at NOCERAL, department of Orthopedics Surgery, School of Medicine. He obtained his Ph.D. from the University of Glasgow in 1992 and in 2018, he further enriched his expertise by acquiring a Tissue Banking Diploma from the National University of Singapore. Throughout his career, Prof. Sharifi has undertaken international research, including working at McGill University in Canada and at Max Plank Institute in Germany. His research output includes over 100 publications in high-impact journals, along with several patented innovations. He has held various administrative and editorial roles in academia, and has served as a peer reviewer for numerous high-impact journals. His dedication to education is evident through his mentorship of undergraduate and postgraduate students, particularly Ph.D. candidates specializing in molecular medicine, tissue engineering, molecular pharmacology, and cell therapy.  Prof. Sharifi's research expertise involves the fields of cell therapy and regenerative Pharmacology, with a particular emphasis on translational medicine. His extensive body of work includes pioneering studies on pharmacological priming, therapeutic angiogenesis, and innovative strategies to enhance the effectiveness of stem cell therapy by manipulating HIF-1α stabilization, especially in the context of diabetes. Additionally, his research activities include bone and cartilage regeneration, employing a diverse array of strategies such as stem cells and biologically derived products like amniotic membrane extract and mesenchymal stem cell-derived secretome. He has also explored the potential of herbal agents in regenerative medicine.  His contributions extend to the development of custom-made bio-implants for addressing large bone defects and the design and production of various wound dressings, with a specific focus on diabetic wound healing. In recent times, Prof. Sharifi has harnessed the transformative power of CRISPR gene editing technology to combat synovial fibrosis induced by osteoarthritis. In summary, Professor Sharifi is an active scientist in the field of Molecular Pharmacology and Regenerative Medicine, exemplifying innovation, and dedication to advancing scientific knowledge for improvement of healthcare and human well-being.  

Dr. Maziah Mat Rosly is an expert on serious games and exergaming for active living. She received her MBBS degree from Manipal Academy of Higher Education in 2011 and obtained her Dual PhD in Exercise Physiology and Health Sciences from Universiti Malaya and The University of Sydney in 2019. She is affiliated with numerous serious games programs built for long-term sustainability, cost-efficient deployment and effective health management. Dr. Maziah is mainly responsible for overseeing the development, design and implementation of serious games for education and innovating virtual reality-based exergames to improve adaptability, reduce carbon footprint and, provide highly cost and space-efficient mechanisms for sports and exercise training. Her latest project involves designing a VR cube e-sports exergame feasible for deployment in East Asian urban cities and for space exploration.

Jiankun Gong publishes on application of media effects theories in the digital context, emerging communication technologies, and computational social science.  He is  also focusing on health communication and how (social) media helps to communicate health and science.  Also, he has interests in migration and student mobility studies. His works have been published at Digital Journalism, Social Media + Society, Journalism among others. He serves as associate editor, peer reviewer at various journals, conferences (ICA, NCA etc.).